GlassScriptPhysician profile
Yikun Wang
NPI 1083241764
$5,116.59
in general payments reported to CMS, 2019-2025
9 companies · $5,117 in 2025
The $5,117 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $5,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,013 · Food and Beverage: $1,022 · Education: $81.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,012.98 |
| Food and Beverage | $1,022.12 |
| Education | $81.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,651.57 | 2025 | Vercise |
| Merz Pharmaceuticals, LLC | $1,547.15 | 2025 | Xeomin |
| Abbott Laboratories | $1,358.69 | 2025 | Infinity, Proclaim |
| Abbvie INC. | $236.24 | 2025 | |
| Neurocrine Biosciences, INC. | $99.36 | 2025 | |
| Medtronic, INC. | $98.63 | 2025 | Percept PC Brainsense |
| Teva Pharmaceuticals USA, INC. | $81.49 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $22.14 | 2025 | Dysport |
| Philips North America LLC | $21.32 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yikun Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.